Citigroup Reiterates Neutral Rating on Texas Capital Bancshares, Inc. (TCBIO)

Market Context

Texas Capital Bancshares, Inc. operates in the Financial Services sector. The stock currently trades at $20.37 with a market capitalization of $938.9M.

Analyst coverage from Citigroup provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Texas Capital Bancshares, Inc..

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Texas Capital Bancshares, Inc.

Among the 10 most recent ratings: 1 Buy, 5 Hold, 4 Sell.

Date	Firm	Rating	Price Target
Jul 24, 2026	Citigroup	Neutral	N/A
Jul 23, 2026	Stephens & Co.	Overweight	N/A
Jul 01, 2026	JP Morgan	Underweight	N/A
Jun 30, 2026	Citigroup	Neutral	N/A
Apr 28, 2026	Citigroup	Sell	N/A

Related Tools: Analyst Ratings Dashboard | View TCBIO Stock Page